1389 related articles for article (PubMed ID: 23519008)
21. Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions.
Beauregard JM; Giraudet AL; Aide N; Hofman MS; Blum R; Drummond E; Roselt P; Hicks RJ
Nucl Med Commun; 2013 Jun; 34(6):521-6. PubMed ID: 23542911
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
23. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
[TBL] [Abstract][Full Text] [Related]
24. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
25. Comparison of whole-body DW-MRI with 2-[
Baratto L; Nyalakonda R; Theruvath AJ; Sarrami AH; Hawk KE; Rashidi A; Shen S; States L; Aboian M; Jeng M; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1689-1698. PubMed ID: 36717409
[TBL] [Abstract][Full Text] [Related]
26. Patlak Reconstruction Using Dynamic 18 F-FDG PET Imaging for Evaluation of Malignant Liver Tumors : A Comparison of HCC, ICC, and Metastatic Liver Tumors.
Kaneko K; Nagao M; Yamamoto A; Yano K; Honda G; Tokushige K; Sakai S
Clin Nucl Med; 2024 Feb; 49(2):116-123. PubMed ID: 38108830
[TBL] [Abstract][Full Text] [Related]
27. Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.
Hu SL; Yang ZY; Zhou ZR; Yu XJ; Ping B; Zhang YJ
Nucl Med Commun; 2013 Jun; 34(6):533-9. PubMed ID: 23503000
[TBL] [Abstract][Full Text] [Related]
28. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.
Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D
Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159
[TBL] [Abstract][Full Text] [Related]
29. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results.
Wetter A; Lipponer C; Nensa F; Beiderwellen K; Olbricht T; RĂ¼bben H; Bockisch A; Schlosser T; Heusner TA; Lauenstein TC
Invest Radiol; 2013 May; 48(5):256-62. PubMed ID: 23462678
[TBL] [Abstract][Full Text] [Related]
31. Exploratory radiomic features from integrated
Baiocco S; Sah BR; Mallia A; Kelly-Morland C; Neji R; Stirling JJ; Jeljeli S; Bevilacqua A; Cook GJR; Goh V
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1478-1484. PubMed ID: 30919055
[TBL] [Abstract][Full Text] [Related]
32. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.
Miyauchi T; Wahl RL
Eur J Nucl Med; 1996 May; 23(5):517-23. PubMed ID: 8698055
[TBL] [Abstract][Full Text] [Related]
33. Impact of attenuation correction of radiotherapy hardware for positron emission tomography-magnetic resonance in ano-rectal radiotherapy patients.
Wyatt JJ; Petrides G; Pearson RA; McCallum HM; Maxwell RJ
J Appl Clin Med Phys; 2024 Mar; 25(3):e14193. PubMed ID: 37922377
[TBL] [Abstract][Full Text] [Related]
34. The role of dynamic, static, and delayed total-body PET imaging in the detection and differential diagnosis of oncological lesions.
Wu Y; Fu F; Meng N; Wang Z; Li X; Bai Y; Zhou Y; Liang D; Zheng H; Yang Y; Wang M; Sun T
Cancer Imaging; 2024 Jan; 24(1):2. PubMed ID: 38167538
[TBL] [Abstract][Full Text] [Related]
35. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
[TBL] [Abstract][Full Text] [Related]
36. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism.
Tateishi U; Nishihara H; Tsukamoto E; Morikawa T; Tamaki N; Miyasaka K
J Comput Assist Tomogr; 2002; 26(2):185-90. PubMed ID: 11884771
[TBL] [Abstract][Full Text] [Related]
37. PET-CT evaluation of 2-deoxy-2-[18F]fluoro-D-glucose myocardial uptake: effect of respiratory motion.
Chin BB; Nakamoto Y; Kraitchman DL; Marshall L; Wahl R
Mol Imaging Biol; 2003; 5(2):57-64. PubMed ID: 14499145
[TBL] [Abstract][Full Text] [Related]
38. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
[TBL] [Abstract][Full Text] [Related]
39. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M
Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214
[TBL] [Abstract][Full Text] [Related]
40. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y
Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]